| |
|
|
|
Oncosec Medical  
|
|
5.19 0.28 (0.06%) |
11-27 13:00 |
|
Open: |
4.97 |
Pre close: |
4.91 |
Target:
|
6.74
|
|
High: |
5.19 |
Low: |
4.92 |
Resistance:
|
5.77
6.74
|
|
Volume: |
70,831 |
Market Cap: |
144M |
Support:
|
4.27
3.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.05
 |
MACD |
MACD(12,26):
|
0.29  |
|
MA(20): |
4.89 |
Signal(12,26,9): |
0.34 |
|
MA(100): |
3.93 |
Stochastic Oscillator |
%K(14,3):
|
58.70 |
|
MA(250): |
2.68 |
%D(3): |
60.87 |
|
Average Volume(K) |
3-Month: |
27522
|
52-Week |
High:
|
5.77 |
|
10-Days: |
22475 |
Low: |
1.04 |
|
RSI |
RSI(14):
|
59.07 |
Change(%): |
142.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-0.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-4.290 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-1.740 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
